Health
mRNA pancreatic cancer vaccine shows promising early results in small trial
A patient in a small trial shows no evidence of pancreatic cancer after receiving an mRNA vaccine, NPR reports.
Photo: this version: Sonarpulse. origenal:Huji / Public domain, via Wikimedia Commons
NPR Health reported that a small clinical trial of an mRNA vaccine targeting pancreatic cancer has yielded encouraging early results.
One patient in the trial is currently showing no evidence of the cancer that was expected to be fatal years ago.
A patient in the trial shows no evidence of pancreatic cancer after receiving the mRNA vaccine, indicating a positive outcome in this case.
Further research and larger trials will be necessary to confirm the vaccine's effectiveness and safety in a broader patient population.
Sources
We read public reporting and official data, confirm what we can, and write our own story. See something wrong? Request a correction.
Comments
No comments yet.
Sign in to comment